miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study

Bethany N. Hannafon,Angela Cai,Cameron L. Calloway,Yi-Fan Xu,Roy Zhang,Kar-Ming Fung,Wei-Qun Ding

DOI: https://doi.org/10.1186/s12885-019-5839-2

IF: 4.638

2019-06-28

BMC Cancer

Abstract:<h3 class="Heading">Background</h3><p class="Para">Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human cancers, including breast cancer.</p><h3 class="Heading">Methods</h3><p class="Para">To clarify this dichotomous role in breast cancer, miR-23b and miR-27b were knocked out using CRISPR/Cas9 gene knockout technology, and the role of endogenous miR-23b and miR-27b was examined in a breast cancer model system in vitro and in vivo.</p><h3 class="Heading">Results</h3><p class="Para">Characterization of the knockout cells in vitro demonstrated that miR-23b and miR-27b are indeed oncogenic miRNAs in MCF7 breast cancer cells. miR-23b and miR-27b knockout reduced tumor growth in xenograft nude mice fed a standard diet, supporting their oncogenic role in vivo. However, when xenograft mice were provided a fish-oil diet, miR-27b depletion, but not miR-23b depletion, compromised fish-oil-induced suppression of xenograft growth, indicating a context-dependent nature of miR-27b oncogenic activity.</p><h3 class="Heading">Conclusions</h3><p class="Para">Our results demonstrate that miR-23b and miR-27b are primarily oncogenic in MCF7 breast cancer cells and that miR-27b may have tumor suppressive activity under certain circumstances.</p>

oncology